| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,650 |
14,765 |
$7.83M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,840 |
35,617 |
$5.63M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
233 |
230 |
$1.37M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,093 |
3,025 |
$474K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
55 |
54 |
$240K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,157 |
2,841 |
$196K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,117 |
3,034 |
$166K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,114 |
4,961 |
$126K |
| 71045 |
Radiologic examination, chest; single view |
7,071 |
6,737 |
$119K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
95 |
88 |
$110K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
42 |
42 |
$108K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,114 |
4,001 |
$102K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
541 |
364 |
$91K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,487 |
2,204 |
$85K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,114 |
3,722 |
$81K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,094 |
6,238 |
$79K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
977 |
891 |
$63K |
| 85027 |
|
15,428 |
13,856 |
$60K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,707 |
3,440 |
$44K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
342 |
329 |
$44K |
| 70450 |
Computed tomography, head or brain; without contrast material |
992 |
920 |
$42K |
| 81001 |
|
12,618 |
11,929 |
$39K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,907 |
1,836 |
$37K |
| 80053 |
Comprehensive metabolic panel |
2,650 |
2,380 |
$36K |
| 71046 |
Radiologic examination, chest; 2 views |
825 |
800 |
$24K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
245 |
230 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
128 |
120 |
$19K |
| 84703 |
|
2,627 |
2,466 |
$19K |
| 93976 |
|
182 |
153 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45 |
33 |
$15K |
| 80047 |
|
423 |
385 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,082 |
1,998 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
68 |
64 |
$13K |
| 87430 |
|
1,233 |
1,208 |
$13K |
| 80076 |
|
2,046 |
1,925 |
$13K |
| 76801 |
|
138 |
116 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
218 |
199 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
3,195 |
2,855 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
251 |
232 |
$8K |
| 84484 |
|
1,915 |
1,530 |
$8K |
| 87634 |
|
188 |
179 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
215 |
211 |
$7K |
| 87420 |
|
740 |
726 |
$7K |
| 88304 |
|
85 |
84 |
$6K |
| 83690 |
|
1,585 |
1,472 |
$5K |
| 84702 |
|
461 |
394 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
79 |
77 |
$3K |
| 83880 |
|
439 |
404 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
59 |
53 |
$2K |
| 87081 |
|
420 |
410 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
248 |
205 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
26 |
24 |
$2K |
| 82248 |
|
969 |
891 |
$1K |
| 74018 |
|
65 |
64 |
$1K |
| 86850 |
|
125 |
117 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
15 |
15 |
$1K |
| 85610 |
|
1,040 |
951 |
$863.61 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,179 |
1,000 |
$851.09 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
336 |
240 |
$777.32 |
| 76818 |
|
12 |
12 |
$604.15 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
579 |
517 |
$589.53 |
| 86901 |
|
656 |
592 |
$585.13 |
| 86900 |
|
656 |
591 |
$585.03 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$515.47 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
564 |
501 |
$502.49 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
18 |
18 |
$483.93 |
| 85730 |
|
483 |
439 |
$474.55 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
24 |
24 |
$449.46 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
24 |
24 |
$382.68 |
| 82731 |
|
18 |
14 |
$381.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
72 |
66 |
$349.34 |
| 83735 |
|
144 |
117 |
$232.08 |
| 80321 |
|
14 |
13 |
$116.39 |
| 87040 |
|
43 |
36 |
$80.26 |
| 83605 |
|
54 |
51 |
$58.32 |
| 86140 |
|
13 |
13 |
$34.89 |
| 81003 |
|
43 |
43 |
$19.09 |
| 87186 |
|
16 |
12 |
$14.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
51 |
38 |
$13.78 |
| J2704 |
Injection, propofol, 10 mg |
28 |
27 |
$6.50 |
| A9270 |
Non-covered item or service |
2,282 |
1,010 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13 |
13 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
34 |
31 |
$0.00 |
| 72170 |
|
14 |
12 |
$0.00 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
339 |
316 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
19 |
19 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
17 |
17 |
$0.00 |